SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-286213
Filing Date
2020-11-05
Accepted
2020-11-05 07:18:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d33613ds3.htm S-3 447341
2 EX-1.3 d33613dex13.htm EX-1.3 15304
3 EX-4.2 d33613dex42.htm EX-4.2 315171
4 EX-4.3 d33613dex43.htm EX-4.3 315700
5 EX-4.4 d33613dex44.htm EX-4.4 29162
6 EX-4.5 d33613dex45.htm EX-4.5 30247
7 EX-5.1 d33613dex51.htm EX-5.1 13445
8 EX-5.2 d33613dex52.htm EX-5.2 6809
9 EX-23.1 d33613dex231.htm EX-23.1 1803
10 GRAPHIC g33613g1103130621068.jpg GRAPHIC 33708
  Complete submission text file 0001193125-20-286213.txt   1222610
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249862 | Film No.: 201288666
SIC: 2834 Pharmaceutical Preparations